• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Get Ready, Pharma: How Point-Of-Care AI Could Transform Commercial Strategy While Improving Patient Outcomes


Sponsored Content

Pharma leaders are increasingly allocating budget toward real-time clinical alerts that integrate with and improve patient care. By investing in algorithms that auto-detect diseases as common as heart failure and as rare as pulmonary arterial hypertension, manufacturers can help accelerate time to diagnosis and treatment, streamline monitoring and identify new patients while starting them on the right therapies faster.

Related Content